Current role
Biotechnology · Healthcare
Chairman, Board Member
2024-06-07–present
Ron Cooper
Chairman
C4 Therapeutics, Inc. (CCCC)Board Member
C4 Therapeutics, Inc. (CCCC)Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsAbout Ron Cooper
Ron Cooper is recorded as Chairman and Board Member at C4 Therapeutics, Inc. (CCCC) since June 7, 2024. C4 Therapeutics, Inc. reported in an 8-K filed June 10, 2024 that Ron Cooper was appointed Chair of the Board, effective June 7, 2024. C4 Therapeutics, Inc. reported in an 8-K filed June 10, 2024 that Ron Cooper was appointed director, effective June 7, 2024. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Kendra R. Adams (CFO and Chief Accounting Officer) and 7 others.
“Mr. Cooper was appointed as the new Chair of the Board”
“On June 7, 2024, the Board of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Ron Cooper as a director of the Company.”
Affiliation history
-
Current
2024-06-07–present
-
Current
2024-06-07–present
Company network
Leadership on record at C4 Therapeutics, Inc.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member
- Owen P. Hughes, Jr. Board Member